findmyKOL

Peter Zimetbaum, MD

Enriched profile

Richard A. and Susan F. Smith Professor of Cardiovascular Medicine, Harvard Medical School; Associate Chief and Director of Clinical Cardiology, Beth Israel Deaconess Medical Center · Beth Israel Deaconess Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusCardiac Arrhythmias and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding2004–2013

Peter Zimetbaum is Richard A. and Susan F. Smith Professor of Cardiovascular Medicine, Harvard Medical School; Associate Chief and Director of Clinical Cardiology, Beth Israel Deaconess Medical Center at Beth Israel Deaconess Medical Center. OpenAlex indexes 335 publications with 13,192 citations (h-index 62); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 18 Oct 2026

Peter J. Zimetbaum, MD, is Richard A. and Susan F. Smith Professor of Cardiovascular Medicine, Harvard Medical School at Beth Israel Deaconess Medical Center / Harvard Medical School. The public record shows 335 publications with 13,192 citations (h-index 62), centered on Cardiac Arrhythmias and Treatments, Atrial Fibrillation Management and Outcomes, Cardiac pacing and defibrillation studies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 9 companies, 2 NIH-funded awards (2004–2013).

  • Most recent indexed publication: 2025 · Circulation. Arrhythmia and electrophysiology
  • Top research focus: Cardiac Arrhythmias and Treatments
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atrial Fibrillation4 trials

Research focus

OpenAlex concept fingerprint
Cardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmiasCardiovascular Syncope and Autonomic Disorders

Works with

trial sponsors and companies reporting payments
Abbott LaboratoriesClinical trials—Industry payments108Boston Scientific CorporationClinical trials—Industry payments70Biosense Webster, Inc.Clinical trials—Industry payments23Medtronic, Inc.Clinical trials—Industry payments16Biotronik Inc.Clinical trials—Industry payments3Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Philips Electronics North America CorporationClinical trials—Industry payments3Beth Israel Deaconess Medical CenterClinical trials2Industry payments—Abbott Medical DevicesClinical trials1Industry payments—Aziyo Biologics, Inc.Clinical trials—Industry payments1Johns Hopkins UniversityClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
335publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

13,192citations

Total citations across indexed works.

62h-index

Hirsch index (OpenAlex). i10-index 143.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2004–2013

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    51%
    Factor Xa inhibitor51%
    Eliquis100%
    Part D≥13 patients
  • Cardiovascular

    49%
    Beta blocker27.5%
    Metoprolol Succinate100%
    Part D<11 patients
    Antiarrhythmic21.6%
    Flecainide Acetate100%
    Part D<11 patients
Where care is delivered (Part B)99.5% facility · 0.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

2 NIH research awards on record, funded 2004–2013 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Mark E. Josephson54Daniel B. Kramer47Jonathan W. Waks39Andrew H. Locke33Patricia Tung33Alfred E. Buxton30André d’Ávila29Enrico G. Ferro26Robert W. Yeh21Matthew R. Reynolds20Warren J. Manning18Alexei Shvilkin18Timothy Maher17Michael G. McLaughlin13Ronuk Modi13Kalon K.L. Ho13Roxana Mehran12Jordana Kron11David A. Cox11Thomas H. Hauser11Robert N. D’Angelo11Cindy L. Grines11Jason Matos11Gregg W. Stone11Duane S. Pinto11Francis Murgatroyd11Kenneth A. Ellenbogen11Frank Bogun11James E. Tcheng11Kyoko Soejima10Lynda E. Rosenfeld10Vasanth Vedantham10Reza Nezafat10Henri Roukoz10Pyotr G. Platonov10Thomas Stuckey10David J. Cohen10Gregory F. Michaud10Xiaokui Gu10Adarsh Bhan10

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/peter-zimetbaum-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/zimetbaump

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • LinkedIn

    linkedin.com/in/peter-zimetbaum-61ab9b6

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Peter-Zimetbaum

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    connects.catalyst.harvard.edu/profiles/display/Person/48486

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connects.catalyst.harvard.edu ↗
  • Other

    health.harvard.edu/authors/peter-zimetbaum-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.harvard.edu ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile: Peter Zimetbaum - Associate Chief and Clinical Director of Cardiology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Albert Einstein College of Medicine of Yeshiva University

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →findadoc.bidmc.org ↗
  • Board Certified

    Internal Medicine - Cardiovascular Disease

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoc.bidmc.org ↗
  • Board Certified

    Internal Medicine - Clinical Cardiac Electrophysiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoc.bidmc.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.